| HOME >> BIOLOGY >> TECHNOLOGY |
Condensed Consolidated Statement of Operations
(U.S. Dollars in Thousands, Except Profit (Loss) Per Share Information)
Three Months Ended Nine Months Ended Year Ended
09/30/07 09/30/06 09/30/07 09/30/06 31/12/06
Sales $4,035 $3,066 $11,789 $10,116 $13,656
Gross profit $1,397 $1,025 $3,827 $3,591 $4,775
Net profit (Loss) $189 $34 $(130) $557 $210
Profit (Loss) per
share $0.02 $0.00 $(0.02) $0.07 $0.03
Weighted
average number
of Shares and
share equivalents
Outstanding
(in Thousands) 7,793 7,703 7,793 7,703 7,715
Consolidated Balance Sheet ,
(U.S $ in thousands)
09/30/07 09/30/06 12/31/06
Cash and cash
equivalents $238 $467 $361
Total current
assets $7,662 $7,055 $7,672
Total current
liabilities $6,442 $4,680 $5,055
Shareholder's
equity $7,151 $7,621 $7,315
Safe Harbor: This press release contains certain forward looking
statements within the meaning of section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934. With the exception
of historical information contained herein, the matters discussed in this
press release involve risk and uncertainties. Actual results could differ
materially from those expressed in any forward looking statement made by or
on behalf of Healthcare Technologies Ltd. Readers are referred to the
documents filed by the company with the Securities Exchange Commission,
specifically the most recent report on Form 20F that
'/>"/>
| SOURCE Healthcare Technologies Ltd Copyright©2007 PR Newswire. All rights reserved |